CN1111524A - Medicated wine for hypertension - Google Patents
Medicated wine for hypertension Download PDFInfo
- Publication number
- CN1111524A CN1111524A CN 95102609 CN95102609A CN1111524A CN 1111524 A CN1111524 A CN 1111524A CN 95102609 CN95102609 CN 95102609 CN 95102609 A CN95102609 A CN 95102609A CN 1111524 A CN1111524 A CN 1111524A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicated wine
- raw materials
- weight proportion
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invented medicinal liquor is prepared from the raw materials of cibotium barometz, parasitic loranthus, root of red-rooted salvia, cassia twig, aucklandia root, root bar of treepeony, root of zhejiang figwort and shaoxing wine. It treats the hypertension bylooking into both its root cause and symptoms and can be used as both medicine and health protective tonic. The clinical effective rate comes up to 97.3%. Said medicinal liquor features palatable, small toxic effect stable curative effect after stopping medication and having also obviously curative effect for complication of hypertension.
Description
The invention belongs to the hypertensive medicated wine of a kind of treatment.
It is a lot of to be used for the treatment of hypertensive medicine clinically, though most of Western medicine can bring high blood pressure down in the recent period, side effect is arranged, and particularly knock-on problem can not get basic solution, and to hypertension with the heart, brain, renal damage do not have specific short yet.Chinese patent medicine then exists curative effect not too high, and general effective percentage is only at 80-90%, or cures the symptoms, not the disease, and curative effect is not consolidated, and late result is not obvious, or problem such as toxic action is big.
The present invention aim to provide a kind of near, late result is good, toxic and side effects is little, can solve the hypertensive medicated wine of treatment " medicated wine for hypertension " of hypertension rebound problem.
For achieving the above object, effective ingredient of the present invention is to adopt following materials of weight proportions (b is Unit Weight part):
Rhizoma Cibotii 35-40b Herba Taxilli 50-55b Radix Salviae Miltiorrhizae 40-45b
Ramulus Cinnamomi 25-30b Radix Aucklandiae 12-15b Cortex Moutan 10-14b
Radix Scrophulariae 50-55b yellow wine 330-650b
Above-mentioned materials of weight proportions is concocted into medicated wine.
The manufacture method of above-mentioned medicated wine is:
1, getting raw material of Chinese medicine Rhizoma Cibotii, Herba Taxilli, Radix Salviae Miltiorrhizae, Ramulus Cinnamomi, the Radix Aucklandiae, Cortex Moutan, Radix Scrophulariae by above-mentioned weight proportion puts into yellow wine and soaked 5-10 days.
2, above-mentioned soak is placed in the high pressure distillation device together with Chinese medicine, adds clear water to flooding the sealed high pressure distillator, slowly be heated to 100-150 ℃, 2-3 the atmospheric pressure that keep-up pressure adds clear water slowly in the heating process, add the 40-60% that water inventory is raw material of Chinese medicine and yellow wine total amount.
3, with above-mentioned distillation medicinal liquid cooling, collect distillation medicated wine, promptly make treatment hypertensive medicated wine " medicated wine for hypertension ".
Instructions of taking: every day 100-150ml, divide and take for 2-3 time.
It is considered herein that kidney master water is the source of vital function, liver master wood is biochemical basis, and the source of vital function does not stop, QI and blood is enriched, can coordinating YIN and YANG, and logical hundred arteries and veins of transferring, so the kidney invigorating can easing the affected liver, easing the affected liver then can the beneficial heart, heart governing blood and vessels, and blood vessels are in harmonious proportion just can take good care of whole body, so the principles of formulating prescriptions of this medicated wine are the kidney invigorating easing the affected liver, the warming YANG activating QI, blood circulation promoting and blood stasis dispelling, this principle meets the hypertension incidence rule.
Rhizoma Cibotii nourishing the liver and kidney bone and muscle strengthening in the side, Herba Taxilli invigorating the liver and kidney, the profit that nourishes blood muscle, the Radix Scrophulariae enriching yin and nourishing kidney, strong water system fire, it is strong that three medicines share enriching yin and nourishing kidney power as monarch drug; The Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, the regulating menstruation removing heat from blood, Ramulus Cinnamomi warming YANG activating QI, the dissipating blood stasis of promoting blood circulation, this two flavor is ministerial drug; Radix Aucklandiae regulating functional activities of qi makes tonify without causing stagnation, is adjuvant drug; Cortex Moutan regulating menstruation, clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling is messenger drug.All medicines cooperates, and the cold and heat equilibrium is mended and not hot, do not stagnate and do not stop up, cool and not cold, not oiliness with fixed attention, the effect of the not only tool vessel softening of yellow wine own, nourishing the liver and kidney in the side, but also can play the pharmaceutically active ingredient evaporable effect in concocting process in other that prevents, thus further improve curative effect.
This medicated wine has training and mends very unit, the kidney tonifying easing the affected liver, and blood circulation promoting and blood stasis dispelling, vessel softening, warming the meridian for promoting the flow of YANG QI, the effect of compensate qi and blood cures mainly symptoms such as hypertension, dizzy, headache, and can improve the hepatorenal damage that angiopathy causes.
This medicated wine is through 260 routine clinical statisticses, and according to " 1979 national cardiovascular epidemiology and crowd prevention and treatment forum " fixed hypertension efficacy assessment standard, total effective rate can reach 97.3%, is higher than the effective percentage of treatment hypertension agents 80-90% commonly used at present.And have no side effect.
Because this medicated wine is whole conditioning to human body, giving consideration to both the incidental and fundamental, and also mouthfeel might as well, taking convenience is simple, so can treat medicine, the tonic that can keep healthy again has higher prevention and therapeutic effect to hypertension, coronary heart disease, arteriosclerosis, the property of medicine is gentle, do not injure internal organs, organ injury patients such as the heart, brain, kidney are had benefiting action, take no any untoward reaction in back and toxic and side effects, not only curative effect is obvious, and efficacy consolidation after the drug withdrawal.After taking this medicated wine in addition, the human body resistance against diseases obviously strengthens, and the body function tissue obtains fine recovery, so complication and cardiac disorder are also had obvious therapeutic action.
Embodiment 1, this routine effective ingredient are to adopt following materials of weight proportions (b is Unit Weight part):
Rhizoma Cibotii 38b Herba Taxilli 53b Radix Salviae Miltiorrhizae 43b
Ramulus Cinnamomi 28b Radix Aucklandiae 13b Cortex Moutan 12b
Radix Scrophulariae 53b yellow wine 480b Mel 92b
Manufacture method:
1, gets seven flavor raw material of Chinese medicine 60kg except that yellow wine, Mel by above-mentioned weight proportion, add the 120kg yellow wine and soaked 7 days;
2, soak and Chinese medicine are packed into place in the cloth bag in the rustless steel high pressure distillation device and be covered with layer 2-3 and filter on the steel castor that steams cloth, add clear water and flood cloth bag, the sealed high pressure distillator, slowly be warming up to 100-150 ℃, keep about 2.5 atmospheric pressure, slowly add clear water in the heating process, add the about 90kg of water inventory.
3, high pressure distillation gained medicinal liquid can obtain about effusive cooling medicinal liquid 160kg after the cooling tube cooling approximately.
4, in the cooling medicinal liquid, add 23kg Mel, bottling sealing after the high-temperature process.
5, with remaining medicinal liquid in the high pressure distillation device after filtration-concentrate-leave standstill more than 20 hours-the Jia protein sugar stirs evenly-granulate-50 ℃ of oven dry in right amount, approximately medicated powder 2050g-is encapsulated, every 0.3g.This capsule can be used for cooperating medicated wine to take.
Instructions of taking:
The wine 100-150ml that takes medicine every day divides clothes 2-3 time;
Join 6 of clothes 0.3g capsules every day, divide clothes 2-3 time;
Present embodiment adds Mel and not only improves mouthfeel, and the effect that recovers internal organs function, vessel softening, blood pressure lowering is arranged.The remaining medicinal liquid of distillation is processed into the utilization rate that capsule has not only improved the medical material effective ingredient, and can be used for cooperating medicated wine to treat.
Embodiment 2, this routine effective ingredient are to adopt following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Rhizoma Cibotii 40b Herba Taxilli 55b Radix Salviae Miltiorrhizae 45b
Ramulus Cinnamomi 30b Radix Aucklandiae 15b Cortex Moutan 14b
Radix Scrophulariae 55b yellow wine 650b Mel 150b
Manufacture method is the same.
Embodiment 3, this routine effective ingredient are to adopt following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Rhizoma Cibotii 35b Herba Taxilli 50b Radix Salviae Miltiorrhizae 40b
Ramulus Cinnamomi 25b Radix Aucklandiae 12b Cortex Moutan 10b
Radix Scrophulariae 50b yellow wine 330b Mel 50b
Manufacture method is the same.
Embodiment 4, this example add following Chinese medicine raw materials by weight proportion again in the raw material that soaks with yellow wine that embodiment 1 or 2 or 3 adopts:
Citron 23b Bulbus Allii Macrostemonis 23b Fructus Trichosanthis 28b
The weight change scope of above-mentioned three flavor medicines is:
Citron 20-25b Bulbus Allii Macrostemonis 20-25b Fructus Trichosanthis 25-30b
We are applicable to the hyperpietic with cardiovascular disease.
Embodiment 5, this example add following Chinese medicine raw materials by weight proportion again in the raw material that soaks with yellow wine that embodiment 1 or 2 or 3 adopts:
Rhizoma dioscoreae 28b Rhizoma Alismatis 28b
The weight change scope of above-mentioned two flavor medicines is:
Rhizoma dioscoreae 25-30b Rhizoma Alismatis 25-30b
We are applicable to the hyperpietic with the nephritis history.
Embodiment 6, this example add following Chinese medicine raw materials by weight proportion again in the raw material that soaks with yellow wine that embodiment 1 or 2 or 3 adopts:
Radix Et Rhizoma Rhei 8b Herba Schizonepetae 13b
The weight change scope of above-mentioned two flavor medicines is:
Radix Et Rhizoma Rhei 6-9b Herba Schizonepetae 12-15b
We are applicable to uremic hyperpietic.
Embodiment 7, this example add following Chinese medicine raw materials by weight proportion again in the raw material that soaks with yellow wine that embodiment 1 or 2 or 3 adopts:
Semen Persicae 11b Flos Carthami 10b Squama Manis 8b Pheretima 18b
The weight change scope of above-mentioned four Chinese medicine is:
Semen Persicae 10-12b Flos Carthami 9-12b Squama Manis 6-9b Pheretima 15-20b
We are applicable to the hyperpietic with the thrombosis history.
Claims (6)
1, treat hypertensive medicated wine " medicated wine for hypertension ", it is characterized in that: this pharmaceutically active ingredient adopts following Chinese medicine raw materials by weight proportion (b is Unit Weight part):
Rhizoma Cibotii 35-40b Herba Taxilli 50-55b Radix Salviae Miltiorrhizae 40-45b
Ramulus Cinnamomi 25-30b Radix Aucklandiae 12-15b Cortex Moutan 10-14b
Radix Scrophulariae 50-55b yellow wine 330-650b
Above-mentioned Chinese medicine raw materials by weight proportion is concocted into medicated wine.
2, medicated wine according to claim 1 is characterized in that: the Mel that also is added with 50-150b in described raw material of Chinese medicine.
3, medicated wine according to claim 1 and 2 is characterized in that: also be added with following Chinese medicine raw materials by weight proportion in described raw material of Chinese medicine:
Citron 20-25b Bulbus Allii Macrostemonis 20-25b Fructus Trichosanthis 25-30b
4, medicated wine according to claim 1 and 2 is characterized in that: also be added with following Chinese medicine raw materials by weight proportion in described raw material of Chinese medicine:
Rhizoma dioscoreae 25-30b Rhizoma Alismatis 25-30b
5, medicated wine according to claim 1 and 2 is characterized in that: also be added with following Chinese medicine raw materials by weight proportion in described raw material of Chinese medicine:
Radix Et Rhizoma Rhei 6-9b Herba Schizonepetae 12-15b
6, medicated wine according to claim 1 and 2 is characterized in that: also be added with following Chinese medicine raw materials by weight proportion in described raw material of Chinese medicine:
Semen Persicae 10-12b Flos Carthami 9-12b Squama Manis 6-9b Pheretima 15-20b
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95102609 CN1111524A (en) | 1995-03-14 | 1995-03-14 | Medicated wine for hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 95102609 CN1111524A (en) | 1995-03-14 | 1995-03-14 | Medicated wine for hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1111524A true CN1111524A (en) | 1995-11-15 |
Family
ID=5074393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 95102609 Pending CN1111524A (en) | 1995-03-14 | 1995-03-14 | Medicated wine for hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1111524A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002032438A1 (en) * | 2000-09-13 | 2002-04-25 | Jiangsu Kanion Pharmaceutical Co. | Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like |
| CN100406054C (en) * | 2006-06-09 | 2008-07-30 | 栾继习 | Chinese-medicinal preparation for treating hypertension and preventing lesion |
| US8067040B2 (en) | 2006-10-18 | 2011-11-29 | Jiangsu Kanion Pharmaceuticals, Co. Ltd. | Cinnamomi and poria composition and uses thereof |
| CN1880437B (en) * | 2006-05-18 | 2011-12-07 | 刘彩霞 | Balsam pear honey vinegar and method for making same |
| CN103495084A (en) * | 2013-10-12 | 2014-01-08 | 安徽燕之坊食品有限公司 | Health-care medicinal liquor for treating high blood pressure as well as preparation method thereof |
-
1995
- 1995-03-14 CN CN 95102609 patent/CN1111524A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002032438A1 (en) * | 2000-09-13 | 2002-04-25 | Jiangsu Kanion Pharmaceutical Co. | Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like |
| US7691387B2 (en) | 2000-09-13 | 2010-04-06 | Jiangsu Kanion Pharmaceutical Co., Ltd | Cinnamomi and poria composition, method to prepare same and uses thereof |
| US8119141B2 (en) | 2000-09-13 | 2012-02-21 | Jiangsu Kanion Pharmaceutical Co. Ltd. | Cinnamomi and poria composition, method to prepare same and uses thereof |
| CN1880437B (en) * | 2006-05-18 | 2011-12-07 | 刘彩霞 | Balsam pear honey vinegar and method for making same |
| CN100406054C (en) * | 2006-06-09 | 2008-07-30 | 栾继习 | Chinese-medicinal preparation for treating hypertension and preventing lesion |
| US8067040B2 (en) | 2006-10-18 | 2011-11-29 | Jiangsu Kanion Pharmaceuticals, Co. Ltd. | Cinnamomi and poria composition and uses thereof |
| CN103495084A (en) * | 2013-10-12 | 2014-01-08 | 安徽燕之坊食品有限公司 | Health-care medicinal liquor for treating high blood pressure as well as preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN1084761A (en) | Bone wound medicine (gushangling) | |
| CN103212040B (en) | Chinese medicinal composition for treatment of seborrheic alopecia | |
| CN106620370A (en) | Traditional Chinese medicine for treating beriberi | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN100389707C (en) | Health medicinal pillow | |
| CN1628760A (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1965996A (en) | Preparation method of Chinese medicinal capsule for treating apoplexy | |
| CN1733242A (en) | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same | |
| CN1111524A (en) | Medicated wine for hypertension | |
| CN103356952A (en) | Chinese medicine composition for treating arrhythmia | |
| CN102198181B (en) | Antithrombotic and thrombosis-eliminating preparation | |
| CN1076619C (en) | Moxiburning medicine for acupoint therapy | |
| CN1228993A (en) | Traditional Chinese medicine for treating tuberculosis | |
| CN1060367C (en) | Technology for making medicated core of treatment and health-care whip and using method thereof | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN103055299B (en) | Traditional Chinese medicine composition for treating slow arrhythmia and preparation method thereof | |
| CN103182035B (en) | Traditional Chinese medicine composition used for treating chronic arrhythmia of elderly people and preparation method of traditional Chinese medicine composition | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1062172C (en) | Medicine for treating cervical spondylopathy | |
| CN1465386A (en) | Chinese medicine preparation for treating cardio-cerebral vascular disease | |
| CN1273851A (en) | Chinese medicine for treating intraocular hemorrhage | |
| CN100594916C (en) | Plaster for reducing the blood pressure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |